Literature DB >> 31449781

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

M Aljurf1, D Weisdorf2, S K Hashmi3, A Nassar4, E Gluckman5, M Mohty6, D Rizzo7, M Pasquini7, M Hamadani7, W Saber7, P Hari7, M Kharfan-Dabaja8, N Majhail9, U Gerges10, Amir Ali Hamidieh11, F Hussain12, A Elhaddad4, H K Mahmoud4, A Tbakhi13, T B Othman14, R M Hamladji15, M A Bekadja16, P Ahmed17, A Bazarbachi18, S Adil19, S Alkindi20, S Ladeb14, D Dennison20, M Patel21, P Lu22, A E Quessar23, S Okamoto24, Y Atsuta25, A Alhejazi26, M Ayas12, S O Ahmed12, N Novitzky27, A Srivastava28, A Seber29, H Elsolh12, A Ghavamzadeh11, D Confer7, Y Kodera30, H Greinix31, J Szer32, M Horowitz7, D Niederwieser33.   

Abstract

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. While this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state of the art treatments including transplantation, by providing financial, technological, legal, ethical and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population, and potentially provide long-term cost-savings by circumventing the need for their citizens to seek care abroad. Costs of establishing HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. Additionally, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation (WBMT) for establishing HSCT programs with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in the resource constrained setting.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bone marrow transplantation; Developing countries; Low income countries

Mesh:

Year:  2019        PMID: 31449781     DOI: 10.1016/j.hemonc.2019.08.002

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  2 in total

1.  Increasing access to allogeneic hematopoietic cell transplant: an international perspective.

Authors:  Vanderson Rocha; Giancarlo Fatobene; Dietger Niederwieser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

Authors:  Dietger Niederwieser; Helen Baldomero; Nosa Bazuaye; Caitrin Bupp; Naeem Chaudhri; Selim Corbacioglu; Alaa Elhaddad; Cristóbal Frutos; Sebastian Galeano; Nada Hamad; Amir Ali Hamidieh; Shahrukh Hashmi; Aloysius Ho; Mary M Horowitz; Minako Iida; Gregorio Jaimovich; Amado Karduss; Yoshihisa Kodera; Nicolaus Kröger; Regis Péffault de Latour; Jong Wook Lee; Juliana Martínez-Rolón; Marcelo C Pasquini; Jakob Passweg; Kristjan Paulson; Adriana Seber; John A Snowden; Alok Srivastava; Jeff Szer; Daniel Weisdorf; Nina Worel; Mickey B C Koh; Mahmoud Aljurf; Hildegard Greinix; Yoshiko Atsuta; Wael Saber
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.